venBio Partners LLC
- SEC CIK
- 0001776382
- Latest filing
- Aug 14, 2026
Holdings in Q4 2022
Holdings as of Dec 31, 2022, filed Feb 14, 2023. Long positions only; changes compare share counts with Q3 2022.
- Positions
- 7
- −1 vs. Q3 2022
- Portfolio value
- $322.5M
- −$109.7M (−25.4%) vs. Q3 2022
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| VTYXVentyx Biosciences, Inc. | COM | 3,461,536 | $113.5M | 35.2% | −1,550,000−30.9% | Reduced | History |
| ALXOAlx Oncology Holdings Inc | COM | 9,699,925 | $109.3M | 33.9% | 00.0% | Unchanged | History |
| HRMYHarmony Biosciences Holdings, Inc. | COM | 1,035,396 | $57.1M | 17.7% | −90,277−8.0% | Reduced | History |
| PHVSPharvaris N.V. | COM | 2,296,710 | $25.8M | 8.0% | 00.0% | Unchanged | History |
| IMPLIPI Legacy Liquidation Co | COM | 2,759,791 | $10.3M | 3.2% | 00.0% | Unchanged | History |
| CINCCinCor Pharma, Inc. | COM | 383,390 | $4.71M | 1.5% | −1,478,866−79.4% | Reduced | History |
| ELEVElevation Acquisition Group Inc. | COM | 1,866,339 | $1.77M | 0.5% | 00.0% | Unchanged | History |
Sold out since Q3 2022 (1)
Positions held at the end of Q3 2022 that are gone from this filing.